ATP7B and ovarian carcinoma: To this end we evaluated the response to cisplatin of two well-known ovarian cancer cell lines, IGROV-CP20 and A2780-CP20, whose tolerance to Pt drugs has been reported to significantly rely on ATP7B [14,22].